"Substantial" vs "high" burden
While we noted that there is substantial burden from influenza virus infection in Bangladesh in 2010-2012, 2 our estimates are not higher than other estimates published from neighboring countries (reviewed in detail here 4 ). Estimates from Kenya, 5 South Africa, 6 and Thailand 7 are comparable to our estimates, and in some instances, higher than estimates for Bangladesh. As such, we do not consider the mortality estimates (6-11 per 100 000 population) in Bangladesh to be high when compared to other countries; however, we do consider 6-11 deaths per 100 000 population to be a substantial burden for the country of Bangladesh. Similarly, the estimated influenzaassociated hospitalization rates in Rwanda (34 per 100 000 popu- 11 and 44 (95% CI: 31-57) per 100 000 population in Zambia. 12 In addition, a global study reported the highest rates of influenzaassociated hospitalization among African children followed by SouthEast Asia and the Western Pacific. 13 Given the estimated burden in these countries, it seems reasonable for policymakers to explore the relative value of influenza prevention and control strategies among these populations. Rwanda experiences increased influenza virus circulation during the long rainy season from January to July. 16 Furthermore, differences in underlying population health status, health systems, and age structure should also be considered when comparing burden estimates from dif- with Brazil, which has one of the lowest population densities among all countries of the world (25 people per square kilometer). 17 Population density may influence influenza virus transmission dynamics and burden of influenza virus infections. 18 Given the important differences in public health systems, and sociodemographic factors between Brazil, Bangladesh, and Rwanda, disparities in the influenza virus disease burden in these countries are entirely possible. A comparative study of influenza disease burden between countries accounting for these differences would be valuable to better understand the effect of influenza virus infection on these different populations.
countries compared to other parts of the world. 19, 20 Specifically, the influenza mortality estimated among <65 years old was higher in South-East Asia during the pandemic year (2009) when compared with seasonal influenza epidemics. 20 In addition, Alonso et al indicated that influenza A(H1N1)pdm09 did not affect mortality rates in Madagascar.
However, a study by Rajatonirina et al, 21 found an increase in the number of deaths during the weeks following the emergence of influenza A(H1N1)pdm09 in the country. Our article, however, did not focus on the pandemic virus, but on seasonal influenza viruses, which are likely to affect burden in populations differently than newly emerged influenza virus when population immunity in specific age groups may be limited. Therefore, our estimated influenza-associated mortality of 6-11 per 100 000 population per year in Bangladesh is a seasonal bur- from that month would not be attributed to influenza nor contribute to the annual mortality rate estimates as multiplying the ARI deaths by 0% influenza positive (D/P * F) would also be zero. Thus, the estimates for Bangladesh did account for the offset between virus circulation and ARI mortality.
Mortality or hospitalization attribution to other underlying conditions or pathogens
The authors also note their concern that we may be attributing influenza virus infections to deaths among persons with preexisting conditions or terminal illnesses. In the survey for all age groups in Bangladesh, the decedents must meet the case definitions as defined in the article and "the disease had to be a new onset and not a progression of a pre-existing condition. 2 " [Page 67. section 2.3]. Therefore, we excluded those deaths where the respondents reported terminal illnesses and the ARI was not of new onset. We agree that there could still be misattribution of disease burden, but one must also consider that we focused our survey on respiratory disease burden, which represents only a portion of total influenza-attributable mortality. Circulatory or other non-respiratory deaths could also be attributed to influenza virus infections. 22 Furthermore, we agree that RSV surveillance and burden estimates are very important to consider in these settings. 23 To address this, an analysis exploring the effect of respiratory syncytial virus (RSV) circulation on ARI deaths among children <5 years of age in Bangladesh is underway and similar studies could be conducted in Rwanda. Nonetheless, the estimated influenzaassociated hospitalization rates among children aged <5 years in Rwanda (168 per 100 000 population) 3 are similar to those of South Africa (156 per 100 000 population), 11 other countries in Africa, 8, 9, 12 and global estimates for Africa (174 per 100 000 population). 13 Whereas the circulation patterns of RSV are poorly understood in Rwanda and other African countries, in South Africa, the RSV season precedes and minimally overlaps with the influenza season. 24 In this situation, misattribution of influenza-vs.
RSV-associated hospitalization or mortality is unlikely to occur.
Nonetheless, irrespective of RSV cocirculation, the attribution of an illness episode to a single pathogen or condition remains difficult.
6 Comparison with IHME estimates
The authors also compared our estimates to those estimated by the Institute for Health Metrics and Evaluation (IHME). The IHME methods for estimating global influenza deaths focus on attributing influenza virus infections to lower respiratory tract infection deaths, 25 while we focused on associating influenza to a wider case definition of acute respiratory infections. The IHME approach attributes a death to a single pathogen or condition as primary cause of death, which requires careful interpretation as some viral pathogens, such as influenza, have been observed to exacerbate some chronic medical conditions, such as asthma or chronic lung and cardiac conditions. Furthermore, more than one pathogen can be involved in the pathogenesis pathway of an illness episode. The methods used by IHME to estimate influenza-associated deaths
are different from what many influenza researchers utilize when they estimate mortality burden. A comparison of the IHME approach to other methods used to estimate global influenza deaths is further discussed in Iuliano et al 26 Lastly, IHME mentions in their limitations that their estimates are not representative of nonhospitalized disease burden, 25 which we measured using community surveys to capture deaths occurring outside of hospitals.
Thus, we would expect our estimates to be higher than the IHME estimates. In Bangladesh, especially in rural areas, healthcare utilization is very low 27 and many deaths take place outside the health system. 28 We therefore do not think IHME estimates for influenza death are comparable with our estimate.
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